{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:20:32Z","timestamp":1774308032157,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.ahj.2014.07.019","type":"journal-article","created":{"date-parts":[[2014,7,30]],"date-time":"2014-07-30T12:30:40Z","timestamp":1406723440000},"page":"698-705.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations"],"prefix":"10.1016","volume":"168","clinical-trial-number":[{"clinical-trial-number":"isrctn72444640","registry":"10.18810\/isrctn"},{"clinical-trial-number":"isrctn75663024","registry":"10.18810\/isrctn"}],"author":[{"given":"Raban V.","family":"Jeger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias E.","family":"Pfisterer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikke","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"von Felten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannes","family":"Alber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero O.","family":"Bonetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Eberli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Erne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Pedrazzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Rickli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren","family":"Galatius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph A.","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.ahj.2014.07.019_bb0130","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators","volume":"339","author":"Leon","year":"1998","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.ahj.2014.07.019_bb0135","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"58","author":"Levine","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.ahj.2014.07.019_bb0140","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","article-title":"Guidelines on myocardial revascularization","volume":"31","author":"Wijns","year":"2010","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ahj.2014.07.019_bb0145","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1161\/CIRCULATIONAHA.106.686048","article-title":"Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment","volume":"116","author":"Airoldi","year":"2007","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.ahj.2014.07.019_bb0150","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1093\/eurheartj\/ehp275","article-title":"Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period","volume":"30","author":"Schulz","year":"2009","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.ahj.2014.07.019_bb0155","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1056\/NEJMoa1009406","article-title":"Drug-eluting versus bare-metal stents in large coronary arteries","volume":"363","author":"Kaiser","year":"2010","journal-title":"N Engl J Med"},{"issue":"9807","key":"10.1016\/j.ahj.2014.07.019_bb0160","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(11)61672-3","article-title":"Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial","volume":"378","author":"Stefanini","year":"2011","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ahj.2014.07.019_bb0165","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.111.059022","article-title":"Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study","volume":"125","author":"Gwon","year":"2012","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.ahj.2014.07.019_bb0010","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/CIRCULATIONAHA.111.071589","article-title":"Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial","volume":"125","author":"Valgimigli","year":"2012","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.ahj.2014.07.019_bb0015","first-page":"2510","article-title":"Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial","volume":"310","author":"Feres","year":"2013","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ahj.2014.07.019_bb0020","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jcin.2011.06.017","article-title":"Dual antiplatelet therapy duration and clinical outcomes following treatment with zotarolimus-eluting stents","volume":"4","author":"Kandzari","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"issue":"9489","key":"10.1016\/j.ahj.2014.07.019_bb0025","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(05)67221-2","article-title":"Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitats Trial (BASKET)","volume":"366","author":"Kaiser","year":"2005","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ahj.2014.07.019_bb0030","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1056\/NEJMoa067731","article-title":"Stent thrombosis in randomized clinical trials of drug-eluting stents","volume":"356","author":"Mauri","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ahj.2014.07.019_bb0035","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ahj.2007.11.011","article-title":"Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and design","volume":"155","author":"Pfisterer","year":"2008","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.ahj.2014.07.019_bb0040","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/eurheartj\/ehl490","article-title":"Targeted stent use in clinical practice based on evidence from the BAsel Stent Cost Effectiveness Trial (BASKET)","volume":"28","author":"Brunner-La Rocca","year":"2007","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.ahj.2014.07.019_bb0045","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM198504043121437","article-title":"The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group","volume":"312","year":"1985","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.ahj.2014.07.019_bb0050","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.ahj.2014.07.019_bb0055","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ahj.2014.07.019_bb0060","first-page":"e166","volume":"113","author":"Smith","year":"2006","journal-title":"Circulation"},{"issue":"48","key":"10.1016\/j.ahj.2014.07.019_bb0065","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jacc.2006.10.026","article-title":"Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents. An observational study of drug-eluting versus bare-metal stents","author":"Pfisterer","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"10.1016\/j.ahj.2014.07.019_bb0070","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1161\/01.CIR.103.15.1967","article-title":"Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials","volume":"103","author":"Cutlip","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ahj.2014.07.019_bb0075","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0735-1097(96)00452-4","article-title":"Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome","volume":"29","author":"Moussa","year":"1997","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ahj.2014.07.019_bb0080","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/01.CIR.94.7.1519","article-title":"Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy. 30-day clinical outcome of the French Multicenter Registry","volume":"94","author":"Karrillon","year":"1996","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ahj.2014.07.019_bb0085","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S0735-1097(02)02374-4","article-title":"Frequency and correlates of coronary stent thrombosis in the modern era: analysis of a single center registry","volume":"40","author":"Orford","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.ahj.2014.07.019_bb0090","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ahj.2014.07.019_bb0095","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.108.799403","article-title":"Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases","volume":"119","author":"van Werkum","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ahj.2014.07.019_bb0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/CIRCULATIONAHA.109.903955","volume":"122","author":"Kimura","year":"2010","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ahj.2014.07.019_bb0105","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.058560","article-title":"Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study","volume":"125","author":"R\u00e4ber","year":"2012","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.ahj.2014.07.019_bb0110","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.108.828541","article-title":"Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC\/AHA Guidelines) Bleeding Score","volume":"119","author":"Subherwal","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ahj.2014.07.019_bb0115","doi-asserted-by":"crossref","first-page":"620-4.e2","DOI":"10.1016\/j.ahj.2008.12.019","volume":"157","author":"Byrne","year":"2009","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.ahj.2014.07.019_bb0120","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ahj.2010.07.038","volume":"160","author":"Mauri","year":"2010","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.ahj.2014.07.019_bb0125","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/CIRCULATIONAHA.111.078923","article-title":"No one-size-fits-all: a tailored approach to antithrombotic therapy after stent implantation","volume":"125","author":"Pfisterer","year":"2012","journal-title":"Circulation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870314004396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870314004396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:52:26Z","timestamp":1757569946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870314004396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0002870314004396"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2014.07.019","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2014.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}